Investment Firm
Overview
MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Aug 14, 2017
Aug 14, 2017
Post Ipo Equity
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
MyoKardia raised an undisclosed amount on 2017-08-14 in Post-IPO Equity
MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Company Funding History
5
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Apr 30, 2015 | Series B - MyoKardia | 5 | - | 46.0M |
Aug 22, 2014 | Venture Round - MyoKardia | 6 | - | 10.0M |
Oct 04, 2012 | Venture Round - MyoKardia | - | 4.0M | |
Sep 20, 2012 | Series A - MyoKardia | 1 | - | 38.0M |
Recent Activity
There is no recent news or activity for this profile.